Published in J Mol Neurosci on October 28, 2017
Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem (2000) 2.86
Opioid receptors. Annu Rev Biochem (2004) 2.71
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell (2007) 2.65
Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol (2008) 2.57
Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem (2006) 2.31
Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol Interv (2002) 2.19
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther (2011) 2.13
Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem (2001) 2.08
Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell (2001) 2.02
G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol (2004) 1.97
G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem (2005) 1.82
Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals (2008) 1.73
Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.70
Reconsolidation of appetitive memories for both natural and drug reinforcement is dependent on {beta}-adrenergic receptors. Learn Mem (2008) 1.60
Lipid rafts, cholesterol, and the brain. Neuropharmacology (2008) 1.38
Postretrieval propranolol disrupts a cocaine conditioned place preference. Neuroreport (2006) 1.35
Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal (2010) 1.35
Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol Ther (2005) 1.30
Signal-dependent translocation of transducin, RGS9-1-Gbeta5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors. Curr Biol (2002) 1.25
TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J Immunol (2004) 1.23
Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem (1997) 1.21
Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol (2006) 1.21
Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma. J Biol Chem (1996) 1.16
The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36. J Biol Chem (2000) 1.14
Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res (2004) 1.11
Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res (2011) 1.07
Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology (2005) 1.07
Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol (1988) 1.06
Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae. Mol Endocrinol (1999) 1.06
Distribution of Glut1 in detergent-resistant membranes (DRMs) and non-DRM domains: effect of treatment with azide. Am J Physiol Cell Physiol (2003) 1.03
Inhibition of β-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement. Neuropsychopharmacology (2011) 1.03
Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus. J Neurochem (1994) 1.02
Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res Mol Brain Res (2001) 1.02
Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res (2007) 0.99
Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine. Neuroscience (2003) 0.97
Distinct mechanisms of regulation by Ca2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles. J Biol Chem (2008) 0.96
Gbetagamma activation site in adenylyl cyclase type II. Adenylyl cyclase type III is inhibited by Gbetagamma. J Biol Chem (2005) 0.96
Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology (2002) 0.94
Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology (2012) 0.93
Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology (1993) 0.91
Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol (2011) 0.89
Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J Neurochem (1998) 0.86
Arrestins: role in the desensitization, sequestration, and vesicular trafficking of G protein-coupled receptors. Prog Mol Biol Transl Sci (2013) 0.85
Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur J Pharmacol (1992) 0.84
Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor. J Pharmacol Exp Ther (1997) 0.84
Role of beta-adrenoceptors in the expression of morphine withdrawal signs. Life Sci (1994) 0.83
Morphine induces short-lived changes in G-protein gene expression in rat prefrontal cortex. Eur J Pharmacol (2001) 0.83
Effect of yohimbine on the development of morphine dependence in the rat: lack of involvement of cortical beta-adrenoceptor modifications. Pharmacol Biochem Behav (1997) 0.82
Important role of adrenergic function in the development of analgesic tolerance to morphine in mice. Jpn J Pharmacol (1986) 0.82
Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure. Neuropharmacology (2006) 0.82
Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity. J Neurochem (2002) 0.80
Changes occur in central adrenoreceptor function following long-term morphine treatment and during morphine withdrawal. Neuropeptides (1984) 0.79
Changes in cortical beta-adrenergic receptor density and neuronal sensitivity to norepinephrine accompany morphine dependence and withdrawal. Brain Res (1987) 0.79
Tolerance and dependence to opiates. Acta Anaesthesiol Scand (1997) 0.79
Postendocytic Sorting of Adrenergic and Opioid Receptors: New Mechanisms and Functions. Prog Mol Biol Transl Sci (2015) 0.79
Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Res (1998) 0.79
Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers. J Mol Neurosci (2005) 0.78
Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. Eur J Pharmacol (1993) 0.78
Antiarrhythmic effect of prolonged morphine exposure is accompanied by altered myocardial adenylyl cyclase signaling in rats. Pharmacol Rep (2012) 0.77
Mechanisms of regulation and function of G-protein-coupled receptor kinases. World J Gastroenterol (2006) 0.77
Mastoparan inhibits beta-adrenoceptor-G(s) signaling by changing the localization of Galpha(s) in lipid rafts. Cell Signal (2007) 0.77
The effect of chronic morphine and cocaine administration on the Gs and Go protein messenger RNA levels in the rat hippocampus. Neuroscience (1994) 0.77
Delay of morphine tolerance by palmitoylethanolamide. Biomed Res Int (2015) 0.77
Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains. Pharmacol Rep (2011) 0.76
Studying GPCR/cAMP pharmacology from the perspective of cellular structure. Front Pharmacol (2015) 0.76
In situ hybridization reveals specific increases in G alpha s and G alpha o mRNA in discrete brain regions of morphine-tolerant rats. Eur J Pharmacol (1993) 0.76
Maturation of rat brain is accompanied by differential expression of the long and short splice variants of G(s)alpha protein: identification of cytosolic forms of G(s)alpha. J Neurochem (2001) 0.76
Prolonged morphine administration alters protein expression in the rat myocardium. J Biomed Sci (2011) 0.76
Endogenous corticotropin releasing factor regulates adrenergic and opioid receptors. Peptides (2002) 0.76
Altered myocardial Gs protein and adenylyl cyclase signaling in rats exposed to chronic hypoxia and normoxic recovery. J Appl Physiol (1985) (2003) 0.76
Brain Reward Circuits in Morphine Addiction. Mol Cells (2016) 0.76
Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits. Med Sci Monit (2010) 0.76
Up-regulation of adenylylcyclases I and II induced by long-term adaptation of rats to morphine fades away 20 days after morphine withdrawal. Biochim Biophys Acta (2011) 0.76
Isolation of plasma membrane compartments from rat brain cortex; detection of agonist-stimulated G protein activity. Med Sci Monit (2009) 0.76
Stability of the beta-adrenergic receptor/adenylyl cyclase pathway of pediatric myocardium after brain death. J Heart Lung Transplant (1994) 0.75